by vowi | Jul 26, 2019 | IC Investors News EN
26. July 2019 CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective...
by vowi | Jul 1, 2019 | IC Investors News EN
1. July 2019 On 1 July 2019, Potasse et Produits Chimiques SAS has joined Vynova Group. The company, based in Thann (France), has been renamed Vynova PPC SAS. The site’s integration is the final step in a journey of continually increasing cooperation and will further...
by vowi | Nov 5, 2018 | IC Investors News EN
5. November 2018 Effective November 1, 2018, International Chemical Investors Group (ICIG) and WeylChem Group have acquired the Homecare, Cellulosics and Synthesis business of Catexel Group from Unilever Ventures. By acquiring Catexel Technologies Ltd. and Catexel...
by vowi | Sep 21, 2018 | IC Investors News EN
21. September 2018 Vynova Group today inaugurated its new, state-of-the-art potassium hydroxide (KOH) membrane electrolysis facility in Tessenderlo, Belgium. The plant is the result of a major conversion project which was concluded in April 2018, ahead of schedule....
by vowi | Sep 11, 2018 | IC Investors News EN
11. September 2018 Effective October 1, 2018, Dr. Uwe Brunk (56) will join International Chemical Investors Group (ICIG) as President of the WeylChem Group of Companies. Uwe Brunk holds a PhD in Organic Chemistry from the Technical University in Berlin and an...
by vowi | Jan 10, 2018 | IC Investors News EN
10. January 2018 Wednesday, 10 January 2018 – Vynova Group has expanded the product portfolio of its Tessenderlo (Belgium) site with potassium carbonate (K2CO3) liquid. The same product is already produced on the site of Potasse et Produits Chimiques SAS (PPC)...
